Correlation Between Aerovate Therapeutics and Rumble

Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Rumble at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Rumble into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aerovate Therapeutics and Rumble Inc, you can compare the effects of market volatilities on Aerovate Therapeutics and Rumble and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Rumble. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Rumble.

Diversification Opportunities for Aerovate Therapeutics and Rumble

0.68

Correlation Coefficient

Aerovate Therapeutics  Rumble

Poor diversification

The 3 months correlation between Aerovate and Rumble is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Rumble Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rumble Inc and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Rumble. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rumble Inc has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Rumble go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Rumble

Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 1.3 times less return on investment than Rumble. But when comparing it to its historical volatility, Aerovate Therapeutics is 1.49 times less risky than Rumble. It trades about 0.15 of its potential returns per unit of risk. Rumble Inc is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  565.00  in Rumble Inc on September 14, 2024 and sell it today you would earn a total of  249.00  from holding Rumble Inc or generate 44.07% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Aerovate Therapeutics  vs.  Rumble Inc

Aerovate Therapeutics

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Rumble Inc

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Rumble Inc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Rumble displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Aerovate Therapeutics and Rumble

The main advantage of trading using opposite Aerovate Therapeutics and Rumble positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Rumble can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rumble will offset losses from the drop in Rumble's long position.

The idea behind Aerovate Therapeutics and Rumble Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.